Facebook Linkedin Mail X Youtube
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe
Search
Facebook Linkedin Mail X Youtube
Cardiovascular News Cardiovascular News
Cardiovascular News Cardiovascular News
  • Home
  • Latest News
  • Features
  • Structural Heart
  • Profiles
  • Videos
  • Events
  • Supplements
  • Past Issues
  • Subscribe

Tag: edoxaban

AHA 2024: Edoxaban an “effective alternative” to warfarin following valve replacement surgery

19th November 2024
Edoxaban may be an effect...

ESC 2021: Edoxaban shown to be noninferior to warfarin for adverse events after TAVI

31st August 2021
Edoxaban is noninferi...

Virtual ACC: Edoxaban non-inferior to warfarin for preventing thromboembolism after surgical bioprosthetic valve replacement

30th March 2020
According to Geu-Ru H...
The results of the safety profile and efficacy of Lixiana study

European trial data ‘reinforce’ safety profile and efficacy of Lixiana

19th December 2019
Daiichi Sankyo Europe has...

Daiichi Sankyo initiates ENVISAGE-TAVI AF study to investigate once-daily edoxaban in atrial fibrillation undergoing TAVI

5th May 2017
The ENVISAGE-TAVI AF ...

Daiichi Sankyo begins ENTRUST-AF PCI study of once-daily edoxaban

6th March 2017
The first patient has bee...
Cardiovascular News

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com


BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy
Facebook Linkedin Mail X Youtube